Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Evaxion Biotech A/S EVAX

Healthcare Biotechnology
Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:EVAX)

Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing

GlobeNewswire 13 days ago

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1

GlobeNewswire November 12, 2024

Evaxion announces business update and third quarter 2024 financial results

GlobeNewswire October 31, 2024

Evaxion to announce business update and third quarter 2024 financial results on October 31

GlobeNewswire October 28, 2024

Strong validation of Evaxion's AI-Immunology(TM) platform in multiple clinical trials

GlobeNewswire October 9, 2024

Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology(TM) platform

GlobeNewswire October 3, 2024

Evaxion significantly expands vaccine development collaboration with MSD

GlobeNewswire September 26, 2024

Evaxion launches improved AI-Immunology(TM) platform for vaccine antigen prediction

GlobeNewswire September 19, 2024

Evaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01

GlobeNewswire September 16, 2024
View More News ››

Opinion & Analysis (NDAQ:EVAX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:EVAX)

Evaxion significantly expands vaccine development collaborat

Just In: $EVAX Evaxion significantly expands vaccine development collaboration with MSDAgreement provides MSD with options to license...
whytestocks - September 26, 2024

Evaxion Biotech Announces Pricing of $15 Million Public Offe

Breaking News: $EVAX Evaxion Biotech Announces Pricing of $15 Million Public Offering | BenzingaCOPENHAGEN, Denmark, Feb. 01, 2024...
whytestocks - February 1, 2024

Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales | Benz

Just In: $EVAX Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales | BenzingaU.S. stocks traded higher this morning, with the Dow...
whytestocks - January 24, 2024

EVAX announced stock split 1-10

Breaking News: $EVAX EVAX announced stock split 1-102024-01-22 08:02:10 ET Evaxion Biotech A/S (EVAX) announced stock split at a ratio...
whytestocks - January 22, 2024

EVAX ...early a.m runner up on NR

Evaxion and Pantherna announce promising preclinical mRNA vaccine data 2023-02-08 03:30 ET - News Release COPENHAGEN, Denmark and...
Iseneschal - February 8, 2023

EVAX ....8 mins to close....still time for Mr. Maggot to

turn this red ; )
Iseneschal - September 21, 2022
View more Bullboard ››

Interactive Capital Partners Corporation

Interactive Capital Partners Corporation

View More »